The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 120:1170-1175, June 1964
doi: 10.1176/appi.ajp.120.12.1170
© 1964 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by BUKI, R. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by BUKI, R. A.

THE USE OF PSYCHOTROPIC DRUGS IN THE REHABILITATION OF SEX-DEVIATED CRIMINALS

RUDOLPH A. BUKI M.D.

Combinations of 25 mg. or 10 mg. amitriptyline and 4, 2, or 1 mg. perphenazine, 3 or 4 times daily, were administered to 40 hospitalized adult males with sociopathic personality characterized by sexual deviation. The treatment period ranged between one and 5 months. These patients also received group psychotherapy.

Results of treatment were graded as satisfactory in 15 patients who can now be considered for release, promising in 16 patients who were greatly improved but who require additional hospitalization, and unsatisfactory in 9 patients who showed no appreciable change. Mild side effects occurred in most patients during the first few days of treatment but these usually disappeared spontaneously without reduction of dosage. Laboratory studies revealed no variations from the pretreatment values.

This combination of an antidepressant and a tranquilizer was of considerable value in the treatment of agitated depression, anxiety, and aggressiveness in severely neurotic patients. The drugs enabled these patients to function better within the hospital community and to become more accessible to psychotherapy which offers the only hope of permanent cure.







Get information about faster international access.

Privacy Policy

Copyright © 1964 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org